China
China VCs get more selective - AVCJ Forum
Chinese venture capital firms are doubling down on areas in which they have domain expertise as the spectrum of opportunities widens, industry participants told the AVCJ Forum.
China electric car maker Xpeng closes $400m Series C
Xpeng Motors, a Chinese electric vehicle manufacturer established by Xiaopeng He, previously founder of web browser UCWeb and a senior executive at Alibaba Group, has raised $400 million in Series C funding.
Primavera raises $3.4b for third China fund
Primavera Capital Group has closed its third China fund at $3.4 billion, having extended the fundraising period by six months.
PAG, Centurium win firm of the year prizes at AVCJ Awards
PAG Asia Capital and Centurium Capital secured the two firm of the year prizes at the 2019 AVCJ Private Equity & Venture Capital Awards, while Renuka Ramnath of India’s Multiples Alternative Asset Management won the AVCJ Special Achievement Award.
Chinese medical device start-up receives $100m
Chinese medical instrument provider Peijia Medical has raised a RMB700 million ($100 million) Series C round from a group including Matrix Partners China and Lilly Asia Ventures.
Alibaba invests $3.3b in logistics affiliate Cainiao
Alibaba Group has enlarged a controlling stake in its PE-backed shipping affiliate Cainiao Smart Logistics Network with a $3.3 billion investment.
China's Qingke trades up on debut after smaller than expected IPO
Q&K International Group, operator of China-based long-term apartment rentals platform Qingke, posted a marginal gain on its US trading debut after raising $45.9 million in an IPO priced at the bottom end of the indicative range.
Singapore's Tembusu seeks $287m for China liquor fund
Singapore private equity firm Tembusu Partners has received a strategic commitment of up to RMB670 million ($96 million) for a RMB2 billion fund targeting the liquor industry in China’s Guizhou province.
CICC, AstraZeneca launch $1b China healthcare fund
China International Capital Corporation (CICC) and global pharmaceutical giant AstraZeneca are looking to raise $1 billion for a fund that will back Chinese healthcare companies as well as international players looking to enter the country.
PE & QSR: Dining disrupted
With ubiquitous delivery services, ordering apps that learn user preferences, and intelligent inventory management, technology is changing China’s restaurant industry. Operators are in a race to stay relevant
SoftBank founder admits to lapses on WeWork
SoftBank founder Masayoshi Son admitted to a lapse in judgment on WeWork while disclosing that SoftBank Vision Fund and SoftBank Group have written down their positions in the beleaguered co-working space provider by a combined $7.7 billion.
Eastern Bell closes first US dollar fund at $365m
China’s Eastern Bell Capital has closed its first US dollar-denominated fund at $365 million, exceeding the target of $350 million.
Investcorp backs $500m Asia food fund
Investcorp has teamed up with China Resources and Fung Investments, the private investment arm of the founding family of Hong Kong consumer goods and supply chain conglomerate Fung Group, to raise a $500 million Asia food fund.
PE & QSR: Ambition on a bun
Many private equity investors think they can make a fast buck from fast dining, but rolling out a Western-style brand in Asia requires discipline on valuation and competence in execution
China Everbright, Investcorp deepen China tech partnership
China Everbright and Investcorp have agreed to combine their respective China technology-focused investment teams and co-manage a recently launched fund targeting the sector.
VCs set for exit as Alibaba buys IDsManager
Alibaba Cloud, the cloud computing unit of Alibaba Group, has agreed to acquire IDsManager, a Chinese cloud-based ID management platform backed by Qiming Venture Partners and Fortune Capital.
Chinese antibody drug developer raises $150m
Akeso Biopharma, a Chinese biotech company specializing in antibody drugs, has raised a $150 million Series D round led by Loyal Valley Capital and Sino Biopharm.
Chinese drone maker EHang targets US listing
Chinese drone manufacturer EHang has filed for a US IPO, potentially delivering a liquidity event for investors including GGV Capital and ZhenFund.
Chinese fresh produce retailer raises $14m
Maison Capital has invested RMB100 million ($14 million) in Sungiven Foods, a Chinese fresh produce retailer looking to replicate the model of US-based Trader Joe's.
ESR raises $1.6b in up-sized HK IPO, gains on debut
Pan-Asian logistics and fund management platform ESR gained 5.4% on its first day of trading in Hong Kong after completing Asia's second-largest IPO of the year.
China property marketplace trades flat after $78m IPO
Chinese online real estate marketplace Fangdd Network raised $78 million in its US IPO, having reduced the size of the offering, and traded flat on its first day on NASDAQ.
Fund focus: J.P. Gan bucks VC fundraising trend
Having spent 12 years at Qiming Venture Partners, J.P. Gan has raised $352 million for his debut fund at Ince Capital Partners. More early-stage consumer internet deals will follow
China car finance player targets US IPO
Meili Auto, a Chinese car financing platform, has filed for US IPO. Its backers include Gaorong Capital, China International Capital Corporation (CICC), and Lingfeng Capital.
China's I-Mab Biopharma pursues US IPO
I-Mab Biopharma, the product of a CBC Group-engineered merger of two Chinese drug developers, has announced plans for a NASDAQ IPO.